A detailed history of Raymond James & Associates transactions in Rad Net, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 87,984 shares of RDNT stock, worth $5.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87,984
Previous 93,198 5.59%
Holding current value
$5.96 Million
Previous $4.54 Million 14.31%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$46.52 - $61.75 $242,555 - $321,964
-5,214 Reduced 5.59%
87,984 $5.18 Million
Q1 2024

Apr 22, 2024

BUY
$33.57 - $48.66 $579,619 - $840,163
17,266 Added 22.74%
93,198 $4.54 Million
Q4 2023

Jan 16, 2024

SELL
$25.42 - $37.19 $115,076 - $168,359
-4,527 Reduced 5.63%
75,932 $2.64 Million
Q3 2023

Oct 24, 2023

BUY
$27.3 - $34.99 $1.47 Million - $1.88 Million
53,682 Added 200.48%
80,459 $2.27 Million
Q2 2023

Jul 25, 2023

BUY
$25.0 - $33.44 $210,600 - $281,698
8,424 Added 45.9%
26,777 $873,000
Q1 2023

Apr 14, 2023

SELL
$18.18 - $25.07 $10,089 - $13,913
-555 Reduced 2.94%
18,353 $459,000
Q4 2022

Feb 08, 2023

BUY
$15.17 - $21.05 $28,322 - $39,300
1,867 Added 10.96%
18,908 $356,000
Q1 2022

May 11, 2022

SELL
$20.47 - $29.82 $2,251 - $3,280
-110 Reduced 0.64%
17,041 $381,000
Q4 2021

Feb 08, 2022

SELL
$26.37 - $34.6 $88,234 - $115,771
-3,346 Reduced 16.32%
17,151 $516,000
Q3 2021

Nov 02, 2021

SELL
$27.55 - $38.15 $37,302 - $51,655
-1,354 Reduced 6.2%
20,497 $601,000
Q2 2021

Aug 11, 2021

SELL
$21.21 - $36.0 $157,420 - $267,192
-7,422 Reduced 25.35%
21,851 $736,000
Q1 2021

May 14, 2021

BUY
$17.73 - $23.98 $140,457 - $189,969
7,922 Added 37.1%
29,273 $637,000
Q4 2020

Feb 12, 2021

BUY
$14.51 - $19.72 $29,020 - $39,440
2,000 Added 10.34%
21,351 $418,000
Q3 2020

Nov 04, 2020

SELL
$13.94 - $17.81 $2,788 - $3,561
-200 Reduced 1.02%
19,351 $297,000
Q2 2020

Jul 28, 2020

BUY
$8.28 - $18.6 $5,796 - $13,020
700 Added 3.71%
19,551 $310,000
Q4 2019

Feb 12, 2020

SELL
$13.9 - $20.33 $8,340 - $12,197
-600 Reduced 3.08%
18,851 $383,000
Q3 2019

Nov 07, 2019

SELL
$13.8 - $15.23 $15,180 - $16,753
-1,100 Reduced 5.35%
19,451 $279,000
Q2 2019

Aug 06, 2019

SELL
$12.06 - $13.79 $25,326 - $28,959
-2,100 Reduced 9.27%
20,551 $283,000
Q1 2019

May 06, 2019

BUY
$10.03 - $15.86 $5,015 - $7,930
500 Added 2.26%
22,651 $281,000
Q4 2018

Feb 11, 2019

SELL
$10.17 - $16.26 $15,763 - $25,203
-1,550 Reduced 6.54%
22,151 $225,000
Q3 2018

Nov 14, 2018

BUY
$13.4 - $15.75 $9,380 - $11,025
700 Added 3.04%
23,701 $357,000
Q2 2018

Aug 14, 2018

BUY
$12.7 - $15.15 $12,065 - $14,392
950 Added 4.31%
23,001 $345,000
Q1 2018

May 14, 2018

BUY
$9.8 - $14.4 $18,620 - $27,360
1,900 Added 9.43%
22,051 $318,000
Q3 2017

Nov 13, 2017

SELL
$7.6 - $11.85 $41,800 - $65,175
-5,500 Reduced 21.44%
20,151 $233,000
Q2 2017

Aug 14, 2017

BUY
N/A
25,651
25,651 $199,000

Others Institutions Holding RDNT

About RadNet, Inc.


  • Ticker RDNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,310,000
  • Market Cap $3.89B
  • Description
  • RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modali...
More about RDNT
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.